AVEO Pharmaceuticals News
The biggest recent CFO moves
AVEO Pharmaceuticals reported third quarter 2013 loss of 47 cents per share.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 7, 2013-- AVEO Oncology (NASDAQ: AVEO) today reported its third quarter 2013 financial results. ... This is an abstract of the original noodl. To continue reading ...